| Literature DB >> 29075329 |
Amira A Moawad1,2, Helmut Hotzel1, Omnia Awad3, Herbert Tomaso1, Heinrich Neubauer1, Hafez M Hafez4, Hosny El-Adawy1,5.
Abstract
BACKGROUND: The global incidence of foodborne infections and antibiotic resistance is recently increased and considered of public health concern. Currently, scarcely information is available on foodborne infections and ESBL associated with poultry and beef meat in Egypt.Entities:
Keywords: Antibiotic resistance; Egypt; Escherichia coli; Integron; Salmonella
Year: 2017 PMID: 29075329 PMCID: PMC5648511 DOI: 10.1186/s13099-017-0206-9
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Sources, number of S. enterica isolates and results of their serovar identification
| Serovar | Poultry | Beef | (Poultry + beef) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Fresh meat | Frozen meat | Fresh organs | Total | Fresh meat | Frozen meat | Fresh organs | Total | ||
|
| 2 | 0 | 1 | 3 (3.3) | 3 | 1 | 2 | 6 (6.7) | 9 (60.0) |
|
| 0 | 1 | 1 | 2 (6.7) | 0 | 0 | 1 | 1 (3.3) | 3 (20.0) |
|
| 1 | 0 | 0 | 1 (3.3) | 1 | 0 | 0 | 1 (3.3) | 2 (13.3) |
|
| 1 | 0 | 0 | 1 (3.3) | 0 | 0 | 0 | 0 (0) | 1 (6.7) |
| Total | 4 | 1 | 2 | 7 (7.8) | 4 | 1 | 3 | 8 (8.8) | 15 (100) |
Sources, number of E. coli isolates and results of their serogroup identification
| Serogroup | Fresh poultry meat | Frozen poultry meat | Fresh poultry organs | Fresh beef meat | Frozen beef meat | Fresh beef organs | Total number of isolates | % of |
|---|---|---|---|---|---|---|---|---|
| O1 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 9.5 |
| O18 | 2 | 1 | 1 | 0 | 0 | 0 | 4 | 19 |
| O20 | 1 | – | 1 | – | – | – | 2 | 9.5 |
| O78 | 1 | 0 | 0 | 1 | 1 | 1 | 4 | 19 |
| O103 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 4.8 |
| O119 | 1 | – | – | 1 | – | – | 2 | 9.5 |
| O126 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 9.5 |
| O145 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 4.8 |
| O146 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 4.8 |
| O158 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 9.5 |
| Total | 6 | 3 | 4 | 3 | 4 | 1 | 21 | 100 |
PCR primers, their sequences and amplification targets used in this study
| Primer | Sequence (5′–3′) | Amplicon size (bp) | Amplification target | References |
|---|---|---|---|---|
|
| ||||
| ECO-f | GAC CTC GGT TTA GTT CAC AGA | 585 |
| [ |
| ECO-r | CAC ACG CTG ACG CTG ACC A | |||
| OMPCF | ATC GCT GAC TTA TGC AAT CG | 204 |
| [ |
| OMPCR | CGG GTT GCG TTA TAG GTC TG | |||
| ENTF | TGT GTT TTA TCT GAT GCA AGA GG | 304 |
| [ |
| ENTR | TGA ACT ACG TTC GTT CTT CTG G | |||
| TYPHF | TTG TTC ACT TTT TAC CCC TGA A | 401 |
| [ |
| TYPHR | CCC TGA CAG CCG TTA GAT ATT | |||
| β-Lactamases | ||||
| TEM-F | ATA AAA TTC TTG AAG ACG AAA | 1080 |
| [ |
| TEM-R | GAC AGT TAC CAA TGC TTA ATC | |||
| OXA-F | TCA ACT TTC AAG ATC GCA | 591 |
| [ |
| OXA-R | GTG TGT TTA GAA TGG TGA | |||
| OXA-F-2 | ATT AAG CCC TTT ACC AAA CCA | Whole | [ | |
| OXA-R-2 | AAG GGT TGG GCG ATT TTG CCA | |||
| OXA-23-F | GAT CGG ATT GGA GAA CCA GA | 501 |
| [ |
| OXA-23-R | ATT TCT GAC CGC ATT TCC AT | |||
| CTX-M-F | CGC TTT GCG ATG TGC AG | 550 |
| [ |
| CTX-M-R | ACC GCG ATA TCG TTG GT | |||
| CTX-M-F2 | CCA GAA TAA GGA ATC CCA TG | Whole | [ | |
| CTX-M-R2 | GCC GTC TAA GGC GAT AAA C | |||
| CMY-F | GAC AGC CTC TTT CTC CAC A | 1007 |
| [ |
| CMY-R | TGG AAC GAA GGC TAC GTA | |||
| CMY-F2 | ACG GAA CTG ATT TCA TGA TG | Whole | [ | |
| CMY-R2 | GAA AGG AGG CCC AAT ATC CT | |||
| SHV-F | TTA TCT CCC TGT TAG CCA CC | 795 |
| [ |
| SHV-R | GAT TTG CTG ATT TCG CTC GG | |||
| Integrons | ||||
| 5′-CS | GGC ATC CAA GCA GCA AG | 152 | Class 1 integron | [ |
| 3′-CS | AAG CAG ACT TGA CCT GA | |||
| hep74 | CGG GAT CCC GGA CGG CAT GCA CGA TTT GTA | 491 | Class 2 integron | [ |
| hep51 | GAT GCC ATC GCA AGT ACG AG | |||
| Plasmid-mediated quinolone resistance gene | ||||
| qnrA-F | ATT TCT CAC GCC AGG ATT TG | 516 |
| [ |
| qnrA-R | GAT CGG CAA AGG TTA GGT CA | |||
| qnrB-F | GAT CGT GAA AGC CAG AAA GG | 469 |
| [ |
| qnrB-R | ACG ATG CCT GGT AGT TGT CC | |||
| qnrS-F | ACG ACA TTC GTC AAC TGC AA | 417 |
| [ |
| qnrS-R | TAA ATT GGC ACC CTG TAG GC | |||
| Plasmid-mediated colistin resistance gene | ||||
| CLR5-F | CGG TCA GTC CGT TTG TTC | 308 |
| [ |
| CLR5-R | CTT GGT CGG TCT GTA GGG | |||
Breakpoint values of antimicrobial agents according to CLSI, 2011 and phenotypic antimicrobial susceptibility profiles of 15 S. enterica isolates used in this study
| Antibiotic class | Antimicrobial agent | Conc. (μg) | Zone diameter (mm) |
|
|
|
| Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | |||
| Penicillin | Amoxycillin–clavulanic acid | 20 | ≤ 13 | 14–17 | ≥ 18 | 5 | 4 | – | – | 2 | – | 1 | – | – | 2 | 1 | – | 8 (53%) | 7 (47%) | – |
| Ampicillin | 10 | ≤ 13 | 14–16 | ≥ 17 | 7 | 2 | – | 2 | – | – | 1 | – | – | 3 | – | – | 13 (87%) | 2 (13%) | – | |
| Cephalosporin | Cefotaxime | 30 | ≤ 22 | 23–25 | ≥ 26 | 7 | 1 | 1 | 2 | – | – | – | 1 | – | 3 | – | – | 12 (80%) | 2 (13%) | 1 (7%) |
| Cefpodoxime | 20 | ≤ 17 | 18–20 | ≥ 21 | 7 | 2 | – | 1 | 1 | – | – | 1 | – | 1 | 2 | – | 9 (60%) | 6 (40%) | – | |
| Ceftazidime | 30 | ≤ 17 | 18–20 | ≥ 21 | 3 | 5 | 1 | – | 2 | – | – | 1 | – | 1 | 2 | – | 4 (26%) | 10 (67%) | 1 (7%) | |
| Ceftriaxone | 30 | ≤ 19 | 20–22 | ≥ 23 | 3 | 6 | – | – | 2 | – | – | 1 | – | 2 | 1 | – | 5 (33%) | 10 (67%) | – | |
| Miscellaneous | Chloramphenicol | 30 | ≤ 12 | 13–17 | ≥ 18 | – | 5 | 4 | – | – | 2 | – | 1 | – | – | 1 | 2 | – | 7 (47%) | 8 (53%) |
| Colistin | 10 | ≤ 11 | 12–13 | ≥ 14 | – | – | 9 | – | – | 2 | – | – | 1 | – | – | 3 | – | – | 15 (100%) | |
| Fluoroquinolone | Ciprofloxacin | 5 | ≤ 15 | 16–20 | ≥ 21 | – | 3 | 6 | – | 1 | 1 | – | 1 | – | – | – | 3 | – | 5 (33%) | 10 (67%) |
| Enrofloxacin | 5 | ≤ 17 | 18–20 | ≥ 21 | 1 | 7 | 1 | – | 1 | 1 | – | 1 | – | – | 2 | 1 | 1 (7%) | 11 (73%) | 3 (20%) | |
| Nalidixic acid | 30 | ≤ 13 | 14–18 | ≥ 19 | 3 | 6 | – | 1 | 1 | – | 1 | – | – | – | 3 | – | 5 (33%) | 10 (67%) | – | |
| Aminoglycoside | Streptomycin | 10 | ≤ 11 | 12–14 | ≥ 15 | 2 | 7 | – | 1 | 1 | – | 1 | – | – | – | 2 | 1 | 4 (26%) | 10 (67%) | 1 (7%) |
| Tetracycline | Tetracycline | 30 | ≤ 11 | 12–14 | ≥ 15 | 3 | 6 | – | 2 | – | – | 1 | – | – | – | 3 | – | 6 (40%) | 9 (60%) | – |
| Sulphonamide | Trimethoprim/sulphamethoxazole | 25 | ≤ 4 | 3 | ≥ 2 | 4 | 2 | 3 | 1 | 1 | – | 1 | – | – | 2 | 1 | – | 8 (53%) | 4 (26%) | 3 (20%) |
S sensitive, I intermediate, R resistant
Breakpoint values of antimicrobial agents according to CLSI, 2011 and phenotypic antimicrobial susceptibility profiles of E. coli isolates used in this study
| Antibiotic class | Antimicrobial agent | Conc. (μg) | Zone diameter (9) |
| Resistance rate | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poultry (15) | Beef (6) | Total (21) | Poultry | Beef | Total | ||||||||||||
| R | I | S | R | I | S | R | I | S | R | I | S | % | % | % | |||
| Penicillin | Amoxycillin–clavulanic acid | 20 | ≤ 13 | 14–17 | ≥ 18 | 10 | 4 | 1 | 3 | 3 | – | 13 | 7 | 1 | 66.7 | 50.0 | 61.9 |
| Ampicillin | 10 | ≤ 13 | 14–16 | ≥ 17 | 12 | 2 | 1 | 3 | 3 | – | 15 | 5 | 1 | 80.0 | 50.0 | 71.4 | |
| Cephalosporin | Cefotaxime | 30 | ≤ 22 | 23–25 | ≥ 26 | 6 | 7 | 2 | 1 | 3 | 2 | 7 | 10 | 4 | 40.0 | 16.7 | 33.3 |
| Cefpodoxime | 20 | ≤ 17 | 18–20 | ≥ 21 | 3 | 12 | – | 2 | 4 | – | 5 | 16 | – | 20.0 | 33.3 | 23.8 | |
| Ceftazidime | 30 | ≤ 17 | 18–20 | ≥ 21 | 5 | 9 | 1 | – | 6 | – | 5 | 15 | 1 | 33.3 | 0 | 23.8 | |
| Ceftriaxone | 30 | ≤ 19 | 20–22 | ≥ 23 | 3 | 5 | 7 | 1 | 3 | 2 | 4 | 8 | 9 | 20.0 | 16.7 | 19.0 | |
| Miscellaneous | Chloramphenicol | 30 | ≤ 12 | 13–17 | ≥ 18 | 3 | 9 | 3 | 1 | 1 | 4 | 4 | 10 | 7 | 20.0 | 16.7 | 19.0 |
| Colistin | 10 | ≤ 11 | 12–13 | ≥ 14 | – | 1 | 14 | – | – | 6 | – | 1 | 20 | – | – | – | |
| Fluoroquinolone | Ciprofloxacin | 5 | ≤ 15 | 16–20 | ≥ 21 | 4 | 3 | 8 | 2 | 2 | 2 | 6 | 5 | 10 | 26.7 | 33.3 | 28.6 |
| Enrofloxacin | 5 | ≤ 17 | 18–20 | ≥ 21 | 2 | 5 | 8 | 1 | 4 | 1 | 3 | 9 | 9 | 13.3 | 16.7 | 14.3 | |
| Nalidixic acid | 30 | ≤ 13 | 14–18 | ≥ 19 | 5 | 12 | 3 | 1 | 2 | 3 | 6 | 14 | 6 | 33.3 | 16.7 | 28.6 | |
| Aminoglycoside | Streptomycin | 10 | ≤ 11 | 12–14 | ≥ 15 | 9 | 5 | 1 | 4 | 2 | – | 13 | 7 | 1 | 60.0 | 66.7 | 61.9 |
| Tetracycline | Tetracycline | 30 | ≤ 11 | 12–14 | ≥ 15 | 12 | 3 | – | 5 | 1 | – | 17 | 4 | – | 80.0 | 83.3 | 81.0 |
| Sulphonamide | Trimethoprim/sulphamethoxazole | 25 | ≤ 4 | 3 | ≥ 2 | 10 | 2 | 3 | 3 | – | 3 | 17 | 2 | 6 | 66.7 | 50.0 | 81.0 |
S sensitive, I intermediate, R resistant
Phenotypic resistance and resistance determinants found in S. enterica isolates in this study
| Source | Serovar | Resistance phenotype | Resistance genes/class 1 integrons |
|---|---|---|---|
| Poultry | |||
| Fresh poultry meat | Typhimurium | CPD, CTX, NAL |
|
| Fresh poultry meat | Typhimurium | AMC, AMP, CPD |
|
| Fresh poultry meat | Enteritidis | AMP, CTX, TET |
|
| Fresh poultry meat | Kentucky | AMC, AMP, NAL, STR, TET, T/S |
|
| Fresh poultry organs (liver) | Typhimurium | AMC, AMP, CPD, CRO, CTX, NAL, T/S |
|
| Fresh poultry organs (liver) | Paratyphi A | AMC, AMP, CAZ CRO, CTX, T/S |
|
| Frozen poultry meat | Paratyphi A | AMC, AMP, CRO, CTX, T/S |
|
| Beef | |||
| Fresh beef meat | Typhimurium | AMP, CAZ, CTX |
|
| Fresh beef meat | Typhimurium | AMP, CAZ, CRO, CTX |
|
| Fresh beef meat | Typhimurium | AMC, CPD, CTX, TET, T/S |
|
| Fresh beef meat | Enteritidis | AMP, CPD, CTX, NAL, STR, TET, T/S |
|
| Fresh beef organs (spleen) | Typhimurium | AMP, CPD, CTX, STR,TET, T/S |
|
| Fresh beef organs (liver) | Typhimurium | AMC, AMP, CPD | – |
| Fresh beef organs (liver) | Paratyphi A | AMP, CPD, CTX |
|
| Frozen beef meat | Typhimurium | AMC, AMP, CAZ, CPD, CRO, CTX, ENR, NAL, STR, TET, T/S |
|
AMC amoxycillin–clavulanic acid, AMP ampicillin, CAZ ceftazidime, CPD cefpodoxime, CRO chloramphenicol, CTX cefotaxime, ENR enrofloxacin, NAL nalidixic acid, STR streptomycin, TET tetracycline, T/S trimethoprim/sulphamethoxazole
Phenotypic resistance and resistance determinants found in E. coli isolates in this study
| Source |
| Resistance phenotype | Resistance genes/class 1 integron |
|---|---|---|---|
| Poultry | |||
| Fresh poultry meat | O1 | STR, TET | – |
| Fresh poultry meat | O18 | AMP, CIP, CPD, NAL, STR, TET, T/S |
|
| Fresh poultry meat | O18 | AMC, AMP, CHL, CIP, CRO, CTX, NAL, STR, TET, T/S |
|
| Fresh poultry meat | O78 | AMC, AMP, CAZ, TET, T/S |
|
| Fresh poultry meat | O119 | AMC, AMP, CAZ, CTX, STR, TET, T/S |
|
| Fresh poultry meat | O20 | AMC, AMP, CPD, TET, T/S |
|
| Fresh poultry organs (liver) | O18 | AMC, AMP, CAZ, CHL, CIP, CRO, CTX, ENR, NAL, STR, TET, T/S |
|
| Fresh poultry organs (liver) | O126 | AMP, CTX, STR |
|
| Fresh poultry organs (gizzard) | O20 | AMC, AMP, STR, T/S |
|
| Fresh poultry organs (liver) | O145 | CAZ, TET | – |
| Frozen poultry meat | O1 | CTX, NAL, TET |
|
| Frozen poultry meat | O18 | AMC, AMP, STR, TET, T/S |
|
| Frozen poultry | 078 | AMC, AMP, CPD | |
| Frozen poultry meat | O146 | AMC, AMP, TET, T/S |
|
| Frozen organ poultry | 078 | AMC, AMP, CAZ, CHL, CIP, CRO, CTX, ENR, NAL, STR, TET, T/S |
|
| Beef | |||
| Fresh beef meat | O119 | CPD | – |
| Fresh beef meat | O158 | CPD, TET | – |
| Fresh beef organs (liver) | O78 | AMC, AMP, CHL, CIP, CRO, CTX, ENR, NAL, STR, TET, T/S |
|
| Frozen beef meat | O103 | STR, TET |
|
| Frozen beef meat | O126 | AMC, AMP, CIP, STR, TET, T/S |
|
| Frozen beef meat | O158 | AMC, AMP, STR, TET, T/S |
|
AMC amoxycillin–clavulanic acid, AMP ampicillin, CAZ ceftazidime, CPD cefpodoxime, CRO chloramphenicol, CTX cefotaxime, ENR enrofloxacin, NAL nalidixic acid, STR streptomycin, TET tetracycline, T/S trimethoprim/sulphamethoxazole